Knowledge center
The place to find all the most innovative research and information on novel biologics and biosimilars.
In October, together with the Warsaw University of Life Sciences [SGGW], we are launching the new Polpharma Biologics...
Latest news
Find out about all the latest developments of our portfolio and our partners products and other news from Polpharma Biologics.
In October, together with the Warsaw University of Life Sciences [SGGW], we are launching the new Polpharma Biologics...
CEBioForum 2024 is an annual international conference for the biotechnology sector and also the largest industry even...
Downloads
You can find all the latest presentations, brochures and fact sheets below covering our solutions and portfolio.
Polpharma Biologics S.A. is required to prepare and publish information on the executed tax strategy in order to fulfill the obligation set forth in Article 27c paragraph 1 in connection with Article 27b paragraph 2 points 1 and 2 of the Corporate Income Tax Act of February 15, 1992. We invite you to read the document.
This Code of Conduct is the first step to showing dedication to upholding continuous excellence in both business and ethical terms, and showing our care and dedication to products, clients and success.
Polpharma Biologics and the University of Warsaw have signed a cooperation agreement in an important step toward building the company’s international scientific cooperation platform.
